Nephros (NASDAQ:NEPH – Get Free Report) is expected to be announcing its earnings results before the market opens on Wednesday, March 5th. Analysts expect the company to announce earnings of ($0.01) per share and revenue of $3.57 million for the quarter. Parties that are interested in participating in the company’s conference call can do so using this link.
Nephros Price Performance
Shares of NASDAQ:NEPH opened at $1.41 on Tuesday. The company has a market capitalization of $14.87 million, a PE ratio of -15.67 and a beta of 1.19. Nephros has a 1-year low of $1.36 and a 1-year high of $3.19. The business has a fifty day moving average price of $1.55 and a 200-day moving average price of $1.60.
Wall Street Analysts Forecast Growth
Separately, Benchmark restated a “speculative buy” rating and set a $5.00 target price on shares of Nephros in a research report on Tuesday, November 12th.
About Nephros
Nephros, Inc, a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.
Read More
- Five stocks we like better than Nephros
- Why Are These Companies Considered Blue Chips?
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- 3 Stocks to Consider Buying in October
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- What is the Nasdaq? Complete Overview with History
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Receive News & Ratings for Nephros Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nephros and related companies with MarketBeat.com's FREE daily email newsletter.
